Beiersdorf AG v Matex Lab Switzerland SA

Link copied
Case Copied 38 min read

TRADE MARKS ACT 1995

DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS

ReOpposition by Beiersdorf AG to extension of protection of International Registration 1435666 (3, 5, 10, 41, 44) (Australian trade mark application 2225414) – NEAUVIA – held by Matex Lab Switzerland SA

Delegate:                 Robert Wilson

Representation:       Opponent: Written submissions by Spruson & Ferguson Pty Ltd

Holder: Written submissions by Corrs Chambers Westgarth

Decision:                   2024 ATMO 65

Trade Marks Act 1995 (Cth): Regulation 17A.33 opposition: ss 42(b), 44, 58, 59, 60, 62A considered – none established – protection may be extended to Australia

Background

  1. Trade mark number 2225414 is the Australian designation of a request made under the Madrid Protocol by Matex Lab Switzerland SA (‘Holder’) to extend protection of the trade mark subject of International Registration 1435666  to Australia. The request is known as an International Registration Designating Australia (‘IRDA’). This decision relates to an opposition to the extension of protection brought by Beiersdorf AG (‘Opponent’) pursuant to reg 17A.33 of the Trade Marks Regulations 1995 (Cth). Details of the IRDA are as follows:

IRDA:

2225414

International Registration:

1435666

Filing Date:

24 September 2021

Specification:

Class 3: (including) cosmetics

Class 5: (including) pharmaceutical preparations; dietary supplements for humans

Class 10: (including) surgical, medical, apparatus and instruments

Class 41: (including) education

Class 44: (including) medical services; hygienic and beauty care for human beings

Full specification appears in the annexure to this decision

(‘Holder’s Goods and Services’)

Trade Mark:

NEAUVIA

(‘Holder’s Trade Mark’)

Endorsement:

The applicant has advised that the words in the Mark have no meaning in English

  1. Any references to sections or regulations, below, are references to sections or regulations of the Trade Marks Act 1995 (Cth) or the Trade Marks Regulations 1995 (Cth), respectively, unless otherwise indicated.

  2. Following publication of notice of the IRDA’s acceptance, the Opponent filed a Notice of Opposition (‘Notice’) consisting of a Notice of Intention to Oppose and a Statement of Grounds and Particulars (‘SGP’). The SGP raised grounds of opposition pursuant to ss 42(b), 44, 58, 58A, 59, 60, 62A. The Holder subsequently filed a Notice of Intention to Defend the opposition.

  3. The Opponent filed Evidence in Support (‘EIS’) of its opposition which consisted of:

    ·Declaration made on 17 October 2022 by Anuschka Roudi, the Head of Corporate Trademarks of the Opponent, with Exhibits AR-1 to AR-58 (‘Roudi declaration’).

  4. The Holder filed Evidence in Answer (‘EIA’) which consisted of:

    ·Declaration made on 19 January 2023 by Dariusz Salamon, the Deputy Chief Finance Officer and Member of the Board of the Holder, with Annexures A to H (‘Salamon declaration’).

  5. The Opponent did not file Evidence in Reply.

  6. Once the time allowed for filing evidence had ended, the Opponent requested to be heard by way of written submissions. The Opponent’s submissions were prepared by the Opponent’s representative, Spruson & Ferguson Pty Ltd. The Holder requested an oral hearing which…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Beiersdorf AG v Matex Lab Switzerland SA and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2024] ATMO 65
Decision Date

CaseChat Overview and Summary

This matter concerned an opposition filed by Beiersdorf AG against an application for extension of protection for the trade mark NEAUVIA, filed by Matex Lab Switzerland SA (referred to as the Holder). The opposition was heard by Robert Wilson, a delegate of the Registrar of Trade Marks. Beiersdorf AG, a company with a long history in cosmetics and skincare, particularly known for its NIVEA brand, opposed the extension of protection for the NEAUVIA mark, which is used by the Holder for a range of medical and cosmetic treatments and products, including soft tissue fillers and cosmeceuticals.

The legal issues before the delegate were whether the grounds of opposition, including allegations of bad faith in the making of the application, had been established. The delegate was required to determine whether to refuse the extension of protection for all or some of the goods and services listed in the application, or to grant it with or without conditions, having regard to the extent to which the grounds of opposition were proven.

The delegate considered the evidence filed by both parties, including declarations from representatives of Beiersdorf AG and the Holder. Ultimately, the delegate found that Beiersdorf AG had failed to establish any of its grounds of opposition, including the claim of bad faith. Consequently, the delegate ordered that the extension of protection for the NEAUVIA trade mark could proceed one month from the date of the decision, subject to any appeal. The Holder was awarded costs against Beiersdorf AG.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

In these circumstances, I am not satisfied that the IRDA was made in bad faith. Accordingly, this ground of opposition is not established.Decision65. The Opponent has failed to establish any of its ground of oppositions. Accordingly, extension of protection of the Holder’s Trade Mark may proceed one month from the date of this decision. If the Registrar has been served with a notice of appeal before that time, I direct that protection shall not occur until the appeal has been decided or discontinued and that the disposition of the IRDA be in accordance with the Court’s order or direction. In accordance with reg 17A.34N(2), WIPO will be notified of the Registrar’s decision.Costs The Holder has sought an award of costs in its favour. I see no reason to depart from the general rule that costs follow the event. As the Opponent has failed to establish a ground of opposition, I award costs against the Opponent under s 221 as per Schedule 8 of the Trade Marks Regulations 1995.Robert WilsonHearing OfficerTrade Mark and Designs Hearings10 April 2024AnnexureThe Holder’s Goods and ServicesClass 3: Cosmetics; lip glosses; cleaning preparations; make-up removing preparations; detergents other than for use in manufacturing operations and for medical purposes; cosmetic preparations for baths; cosmetic preparations for slimming purposes; make-up; cosmetic creams; skin whitening creams; lotions for cosmetic purposes; make-up preparations; beauty masks; oils for cosmetic purposes; hair lotions; after-shave lotions; sunscreen preparations; cosmetic preparations for eyelashes; cosmetic preparations for skin care; cosmetic kits; cosmetic preparations for skin renewal; body lustre preparations for cosmetic purposes; wrinkle-minimizing skin care preparations; cosmetic preparations for skin renewal; anti-ageing effect, anti-ageing, anti-pollution and anti-sagging cosmetics; cosmeceuticals; cosmetics with complementary medical effects (cosmeceuticals); cosmetic products with added medical properties (cosmeceuticals): cosmeceuticals for cosmetic purposes; cosmeceuticals for skin care after aesthetic medicine treatment; anti-aging, regenerative and skin protective cosmeceuticals; cosmeceuticals with fractional hyaluronic acid; cosmetics, concealers and fillers for lines and wrinkles, anti-aging skin care preparation, anti-aging, regenerative and skin protective cosmetics and preparations, beauty serums with anti-aging properties, cosmetic preparations for skin care, cosmetics for use in the treatment of wrinkled skin; all these goods being sold exclusively in: medical clinics, medical aesthetic clinics, cosmetics and plastic surgery clinics as well as in medical spa and aesthetic medicine salons.Class 5: Pharmaceutical preparations; dietetic food and substances adapted for medical use; dietary supplements for humans; amino acids for medical purposes; protein dietary supplements; albumin dietary supplements; chemical preparations for pharmaceutical purposes; chemical preparations for medical purposes; chemico-pharmaceutical preparations; tissues impregnated with pharmaceutical lotions; disinfectants for hygiene purposes; pharmaceutical preparations; acids for pharmaceutical purposes; medicinal infusions; lotions for pharmaceutical purposes; mineral food supplements; eyepatches for medical purposes; medical preparations for slimming purposes; slimming pills; nutritional supplements; pomades for medical purposes; pharmaceutical preparations for skin care; serums; antioxidant pills; hair growth preparations; disinfectant soap; sanitizer and disinfectant liquids; disinfection gel for hands; mineral food supplements; medical preparations for slimming purposes; pharmaceutical, pharmacological, chemical preparations and products for medical purposes; pharmaceutical, pharmacological and chemical preparations and products for use in aesthetic medicine and for skin care; cosmeceuticals for medical or therapeutic purposes; skin care preparations for medical use; dermatological products and preparations; pharmaceutical, pharmacological and chemical preparations sold in prefilled syringes; filled syringes for medical purposes [containing pharmaceuticals]; pre-filled syringes for medical use; injectable dermal fillers; medicated skin lotions, medicated skin creams, medicated skin tonics, medicated skin care preparations, medicated preparations for skin treatment sold exclusively in: medical clinics, medical aesthetic clinics, cosmetics and plastic surgery clinics as well as in medical spa and aesthetic medicine salons.Class 10: Surgical, medical, apparatus and instruments; apparatus for use in medical analysis; anaesthetic apparatus; microdermabrasion apparatus; vibromassage apparatus; surgical apparatus and instruments; diagnostic apparatus for medical purposes; electrodes for medical use; needles for medical purposes; surgical implants [artificial materials]; syringes for injections; esthetic massage apparatus; lasers for medical purposes; massage apparatus; anaesthetic masks; masks for use by medical personnel; medical apparatus and instruments; body rehabilitation apparatus for medical purposes; injectors for medical purposes; syringes for medical purposes; vaginal syringes; surgical, medical devices; apparatus, devices and instruments to be used in dermatology, cosmetology, plastic surgery and aesthetic medicine; surgical and medical apparatus, instruments and devices used for electrosurgical, radiofrequency, laser, infrared or ultrasound treatment and procedures; surgical and medical apparatus, instruments and devices used for thermal lifting, skin photobiostimulation and cosmetology; surgical, medical apparatus, devices and instruments incorporating lasers; ultrasound surgical, medical apparatus, devices and instruments; radiofrequency medical and surgical apparatus, devices and instruments; infrared medical and surgical apparatus, devices and instruments apparatus for use in medical analysis; disposable hypodermic and inflation syringes for medical and surgical use; disposable needles for hypodermic syringes; syringes and needles for medical aesthetics purposes.Class 41: Education; providing of training; education information; practical training [demonstration]; arranging and conducting of conferences; arranging and conducting of congresses; arranging and conducting of workshops [training]; arranging and conducting of seminars; arranging and conducting of symposiums; organization of exhibitions for cultural or educational purposes; publication of electronic books and journals on-line; providing on-line electronic publications, not downloadable; publication of books; publication of texts other than publicity texts; academies [education]; provision of medical instruction courses; education services, training courses and teaching relating to aesthetics medicine and use of surgical and medical apparatus, devices and instruments; arranging of beauty contests.Class 44: Medical services; hygienic and beauty care for human beings; plastic surgery; beauty salons; medical clinic services; health spa services; cosmetics and plastic surgery clinic services; aesthetics medicine services; medical spa services; aesthetics medicine salons; providing information about beauty, health and in the fields of aesthetics medicine; providing medical information via website.

Ratio Decidendi

Legal Principle Established

The Holder filed Evidence in Answer (‘EIA’) which consisted of: ·Declaration made on 19 January 2023 by Dariusz Salamon, the Deputy Chief Finance Officer and Member of the Board of the Holder, with Annexures A to H (‘Salamon declaration’). The Opponent did not file Evidence in Reply. Once the time allowed for filing evidence had ended, the Opponent requested to be heard by way of written submissions. The Opponent’s submissions were prepared by the Opponent’s representative, Spruson & Ferguson Pty Ltd. The Holder requested an oral hearing which was scheduled for 5 April 2024. Following preliminary discussions at the hearing the Holder chose to rely on written submissions only—those submissions were prepared and filed prior to the hearing by Corrs Chambers Westgarth. The opposition was decided as required by reg 17A.34N which relevantly provides that, unless the proceedings are discontinued or dismissed, the Registrar must decide:(a)to refuse protection in respect of all the goods or services listed in the IRDA; or(b)To extend protection in respect of some or all of the goods or services listed in the IRDA (with or without conditions or limitations);having regard to the extent (if any) to which the grounds on which the IRDA was opposed have been established. I have decided this matter in my capacity as a delegate of the Registrar of Trade Marks, based on the material discussed above.The Opponent According to the Roudi declaration:[The Opponent] was founded 130 years ago and is one of the world’s leading branded goods companies with leading global brands in a number of different areas, including in the cosmetic, and skin care (medicated and non-medicated) areas. …One of the more important brands for [the Opponent] is the NIVEA brand, which is used across a number of products. [The Opponent’s] range of NIVEA branded products include cosmetic and personal care products, including various creams, lotions, moisturisers, lip balms, scrubs and wipes …[The Opponent] currently owns more than one hundred Australian Trade Mark Registrations (or pending Australian Trade Mark Applications) for or including the term NIVEA for various goods and services … Some examples of the trade marks registered by the Opponent are provided below (‘NIVEA Examples’). According to the Salamon declarationITP SA and [the Holder] are part of the MATEX LAB Capital Group.[The Holder] is the owner of all of ITP SA's common shares. Until recently, ITP SA was particularly the owner of all rights associated with [the IRDA]. In December 2021, ownership of all intellectual property rights owned by ITP SA were transferred to [The Holder]. For the sake of simplicity, for the remainder of this decision, ITP SA will be referred to as the Holder. It was further declared in the Salamon declaration:[The Holder] started developing the NEAUVIA brand and products in 2012 in Poland and Italy.The name and mark NEAUVIA has, since 2012, been used as the name of the business and as the brand name for its products and services.The name and mark NEAUVIA was originally selected by Mr Gabriele Drigo, the President and CEO of NEAUVIA North America. It was chosen to reflect the brand's ethos of a ‘new way’ (or ‘nuova via’ in Italian) of approaching medical and cosmetic treatment and products. …The Neauvia business has, since 2012, offered a range of products and services that focus primarily on non-invasive cosmetic and medical treatments. NEAUVIA is [the Holder’s] leading brand for medical and beauty care devices … soft tissue fillers … and organic cosmeceuticals …Grounds of Opposition, Onus and Standard of Proof